19/11/2020
Nuffield Department of Population Health in collaboration with Health Economics Research Center(HERC) and University of Oxford launches research survey on COVID-19 Vaccination.
Brief Description of Research
A key strategy for ending the COVID-19 pandemic will be an effective vaccine. Clinical trials are underway for the Oxford COVID-19 vaccine, and there are 100 other vaccines at various stages of development. While enormous research effort and resources have been put into vaccine development, there is currently no evidence-based framework for the allocation of a vaccine to both maximize outcomes and ensure an equitable distribution. If the results of one or more trials indicate that a vaccine offers protection against COVID-19, governments will have to make immediate decisions on how to allocate available supplies. In many countries, these will not be sufficient for universal vaccination, and so choices will need to be made as to which groups are prioritized to receive a vaccine.
It will be essential both ethically and politically that the vaccine allocation receives public input on which different types of needs should be prioritized (e.g. essential workers versus those at highest risk of dying of COVID-19). The CANDOUR project will conduct national representative surveys in twelve countries in anticipation of trial results being published later this year. It will be used to help develop a fair and efficient allocation mechanism to facilitate vaccine prioritization.
The team of scholars participating in this global project, and described below, have stellar international reputations for the design and implementation of studies concerning public health attitudes and behavior. They also have been on the forefront of theoretical modelling and econometric estimation methods that will be essential for the success of this project.
The Principal Investigator on The Oxford COVID-19 Vaccine Policy project is Professor Philip Clarke. The current team of scholars collaborating on the project include the following:
Professor Philip Clarke
Director, Health Economics Research Centre
Nuffield Department of Population Health
Frauke Becker
Nuffield Department of Population Health
Mariana Blanco
Facultad de Economia, Universidad del Rosario
Bogota
Jean-Francois Bonnefon
Toulouse School of Economics
Toulouse
John Buckell
Nuffield Department of Population Health
Ray Duch
Nuffield College
University of Oxford
Jorge Friedman
Dean, Faculty of Administration and Economics
University of Santiago Chile
Stephane Hess
Director, Choice Modelling Centre, Institute for Transport Studies
University of Leeds
Juan Vargas
Facultad de Economia, Universidad del Rosario
Bogota
Peter Loewen
Munk School of Global Affairs
University of Toronto
Alessia Melegaro
University of Bocconi
Milan
Pavan Mamidi
Director, Center for Social and Behavioral Change
New Delhi, India
Laurence Roope
Nuffield Department of Population Health
University of Oxford
Mara Violato
Nuffield Department of Population Health
University of Oxford
For more information visit our website at https://oxford-candour.com
A key strategy for ending the COVID-19 pandemic will be an effective vaccine. Clinical trials are underway for the Oxford COVID-19 vaccine, and there are 100 other vaccines at various stages of development. While enormous research effort and resources have been put into vaccine development, there is...
